INSULIN RESISTANCE, DIABETES & CARDIOVASCULAR DISEASE

Liver meeting

Wednesday October 10, 2007
1:00 pm-6:00 pm
BOSTON MARRIOTT, NEWTON, MA

This symposium is FREE for participants of the 5th WCIRS

(select this session when registering for main session)
Click here to register ONLY for this session ($80)
Program
Chair:Arun Sanyal, MD
1:00 pm
Opening Remarks
Arun Sanyal, MD
Yehuda Handelsman,MD
SESSION ONE
1:05 pm
Nonalcoholic fatty liver: inconsequential finding or silent killer
Mary Rinella, MD
1:30 pm
Nonalcoholic steatohepatitis: disease progression and contribution to mortality
Arthur McCullough, MD
1:55 pm
Can NAFLD be diagnosed, graded and staged without a liver biopsy?
Detlief Schuppan,MD PhD
2:20 pm-
2:30 pm
Question and Answers Panel Discussion
SPECIAL LECTURE
2:30 pm
NAFLD: Update on Pathogenesis
Arun J Sanyal, MD
3:00 pm- 3:30pm
Refreshment Break
SESSION TWO
3:30pm
Treatment of NAFLD:Is bariatrics the answer?
Mary Rinella , MD
3:55 pm
Glitazones for NASH: magic bullet or double edged sword?
Steven Harrison, MD
4:20 pm
Emerging therapies for NAFLD
Arun J Sanyal, MD
4:45 pm-
5:00 pm
Question and Answers Panel Discussion
POINT COUNTER POINT
Chair:Arun Sanyal, MD
Is it time to screen the population at risk for NAFLD?
5:00pm
Yes:Steven Harrison, MD
5:15pm
No:Arthur McCullough, MD
5:30pm
Question and Answer Panel Discussion
This is a CME activity
Physicians-Int Physicians-Nurses-Pharmacists-Physician Assistants-Dietitians

Jointly Sponsored by
-PESI LLC -Aspen CME services
-Metabolic Endocrine Education Foundation

Partially Supported by
Ethicon-Endosurgery

Administrated by
The Metabolic Institute of America

In association with

5th Annual World Congress
on the
Insulin Resistance Syndrome

Endorsed by
-American Association for Study of Liver Diseases (AASLD)
-European Association for the Study of Liver Disease (EASL)